Also New BRILINTA Savings Card Program Will Offer Savings to Eligible Patients
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE: AZN) today announced that BRILINTA™ (ticagrelor) tablets, a new oral antiplatelet therapy, is now available in pharmacies in the United States.
